Search Results - "Deterding, T"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Biodistribution and Radiation Dosimetry of the Dopamine Transporter Ligand [18F]FECNT by Deterding, Todd A, Votaw, John R, Wang, Chris K, Eshima, Dennis, Eshima, Lori, Keil, Robert, Malveaux, Eugene, Kilts, Clinton D, Goodman, Mark M, Hoffman, John M

    Published in The Journal of nuclear medicine (1978) (01-02-2001)
    “…18F-labeled 2 beta-carbomethoxy-3beta-(4-chlorophenyl)-8-(-2-fluoroethyl)nortropane ([18F]FECNT) is a recently developed dopamine transporter ligand with…”
    Get full text
    Journal Article
  2. 2

    Biodistribution and radiation dosimetry of the dopamine transporter ligand by Deterding, T A, Votaw, J R, Wang, C K, Eshima, D, Eshima, L, Keil, R, Malveaux, E, Kilts, C D, Goodman, M M, Hoffman, J M

    Published in The Journal of nuclear medicine (1978) (01-02-2001)
    “…18F-labeled 2 beta-carbomethoxy-3beta-(4-chlorophenyl)-8-(-2-fluoroethyl)nortropane ([18F]FECNT) is a recently developed dopamine transporter ligand with…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Reproducibility of A B MAX Measure Using a NEW 18 F Dopamine Transporter Ligand by Votaw, J R, Deterding, T, Hoffman, J M, Kilts, C, Votaw, D B, Giroux, M, Camp, V M, Martarello, L, Malveaux, E, Goodman, M M

    Published in NeuroImage (Orlando, Fla.) (01-05-1998)
    “…Using a new dopamine transporter ligand, 2I3-carbomethoxy-313-(4-chloropheny1)-8-(2-[F-18lfluoroethy1)nortro-pane (FECNT), the intra-subject variability of…”
    Get full text
    Journal Article